Precision chemo blitz aims to spare patients major surgery in rare cancer fight
NCT ID NCT07320508
Summary
This study is testing a new, personalized treatment strategy for a rare and aggressive cancer in the nasal and sinus area. First, patients receive three sessions of chemotherapy delivered directly to the tumor to shrink it. Based on how well the tumor responds, doctors then tailor the next steps: some patients may have surgery followed by radiation, while others might avoid major surgery and receive only precise radiation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOID CYSTIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eye and ENT Hospital, Fudan University
RECRUITINGShanghai, Xuhui Strict, 200031, China
Conditions
Explore the condition pages connected to this study.